Genentech, Inc`s Profile
This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.
How does the overall patent portfolio of Genentech, Inc look like?
Total Applications: | 23 |
Granted Patents: | 9 |
Grant Index | 47.37 % |
Abandoned/Rejected Applications: | 10 (52.63%) |
In-Process Applications: | 4 |
Average Grant Time: | 3.45 Years |
Average Office Actions: | 2.22 |
Which Technology Area Genentech, Inc is filing most patents in? (Last 10 years)
Art Unit | Definition | Total Applications |
1642 | Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology | 3 |
1625 | Organic Chemistry | 2 |
1627 | Organic Chemistry | 2 |
1644 | Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology | 2 |
1647 | Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology | 2 |
How many patents are Genentech, Inc filing every year?
Year | Total Applications |
2022 | 0* |
2021 | 0* |
2020 | 0 |
2019 | 0 |
2018 | 1 |
*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published
Recently filed patent applications of Genentech, Inc in USPTO?
Abstract:
Publication date: 2022-01-27
Applicant: Genentech, Inc
Inventors: Mark Zak
Publication number: US20220002437A1
Abstract:
Publication date: 2022-01-06
Applicant: Genentech, Inc
Inventors: Cheung Jeanne
Publication number: US20210401392A1
Abstract:
Publication date: 2021-12-30
Applicant: Genentech, Inc
Inventors: Fredrickson Jill Osborn
How are Genentech, Inc’s applications performing in USPTO?
Application Number | Title | Status | Art Unit | Examiner |
17449398 | Therapeutic Compounds And Compositions, And Methods Of Use Thereof | – | OPAP | Central, Docket |
17483281 | Methods Of Treating Cancers Using Pd-1 Axis Binding Antagonists And Taxanes | Application Undergoing Preexam Processing | 1644 | – |
17473495 | Deep Convolutional Neural Networks For Tumor Segmentation With Positron Emission Tomography | Docketed New Case – Ready for Examination | OPAP | Central, Docket |
17392943 | Optimized Antibody Compositions For Treatment Of Ocular Disorders | Application Undergoing Preexam Processing | 1647 | – |
17386385 | Compositions And Methods For Stabilizing Protein-Containing Formulations | Docketed New Case – Ready for Examination | OPAP | Central, Docket |